GSA Capital Partners’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$311K Sell
21,470
-100,592
-82% -$1.17M 0.02% 1226
2025
Q4
$1.17M Buy
122,062
+80,319
+192% +$769K 0.1% 274
2025
Q3
$392K Buy
+41,743
New +$399K 0.03% 1019
2025
Q1
Sell
-11,576
Closed -$191K 1621
2024
Q4
$191K Sell
11,576
-19,899
-63% -$392K 0.01% 1425
2024
Q3
$777K Sell
31,475
-8,087
-20% -$210K 0.06% 623
2024
Q2
$1M Sell
39,562
-4,275
-10% -$111K 0.07% 499
2024
Q1
$1.11M Sell
43,837
-14,539
-25% -$352K 0.09% 371
2023
Q4
$1.32M Buy
58,376
+6,738
+13% +$139K 0.11% 265
2023
Q3
$962K Buy
+51,638
New +$1.07M 0.08% 414
2023
Q2
Sell
-18,729
Closed -$538K 1493
2023
Q1
$538K Buy
+18,729
New +$557K 0.05% 663
2022
Q1
Sell
-9,717
Closed -$348K 1384
2021
Q4
$348K Sell
9,717
-9,704
-50% -$388K 0.04% 836
2021
Q3
$827K Sell
19,421
-21,434
-52% -$883K 0.08% 403
2021
Q2
$1.77M Buy
40,855
+26,385
+182% +$1.12M 0.2% 76
2021
Q1
$590K Buy
+14,470
New +$549K 0.1% 266
2020
Q2
Sell
-11,273
Closed -$326K 608
2020
Q1
$326K Buy
11,273
+1,662
+17% +$67.2K 0.08% 433
2019
Q4
$498K Buy
9,611
+21
+0.2% +$1.22K 0.06% 652
2019
Q3
$526K Sell
9,590
-416
-4% -$21.4K 0.07% 520
2019
Q2
$406K Buy
+10,006
New +$365K 0.05% 794
2019
Q1
Sell
-13,598
Closed -$457K 1414
2018
Q4
$457K Buy
13,598
+8,120
+148% +$293K 0.05% 605
2018
Q3
$231K Buy
+5,478
New +$216K 0.01% 1436
2017
Q2
Sell
-5,102
Closed -$222K 1653
2017
Q1
$222K Buy
+5,102
New +$244K 0.01% 1519
2016
Q4
Sell
-20,520
Closed -$982K 1731
2016
Q3
$982K Buy
+20,520
New +$1.01M 0.05% 618
2016
Q2
Sell
-12,134
Closed -$543K 1719
2016
Q1
$543K Sell
12,134
-10,005
-45% -$406K 0.03% 956
2015
Q4
$845K Buy
22,139
+2,796
+14% +$107K 0.04% 823
2015
Q3
$616K Sell
19,343
-3,200
-14% -$112K 0.03% 995
2015
Q2
$745K Buy
22,543
+5,744
+34% +$205K 0.03% 1104
2015
Q1
$692K Buy
16,799
+5,400
+47% +$218K 0.03% 1166
2014
Q4
$464K Sell
11,399
-16,823
-60% -$658K 0.03% 976
2014
Q3
$1.03M Sell
28,222
-481
-2% -$20.8K 0.05% 461
2014
Q2
$1.33M Buy
28,703
+6,555
+30% +$292K 0.06% 483
2014
Q1
$910K Buy
22,148
+1,398
+7% +$52K 0.06% 389
2013
Q4
$792K Buy
20,750
+1,792
+9% +$55.3K 0.06% 508
2013
Q3
$454K Buy
18,958
+7,300
+63% +$164K 0.04% 858
2013
Q2
$198K Buy
+11,658
New +$168K 0.02% 1097

Other funds holding ANIK